Digital therapeutics for ADHD like Lumosity, Meta Quest, and EndeavorRx may provide new ways to manage ADHD symptoms and monitor related health conditions.
WAKE FOREST Revibe Technologies will invest in the clinical and regulatory development of its flagship product, Revibe Connect, a digital therapeutic smartwatch device powered by artificial intelligence after closing $3 million in funding led by the Carolina Angel Network. To lead this effort, company founder Rich Brancaccio will transition from the role of CEO to the role of chief innovation officer, and the company will hire Joseph Koziak as its new CEO, it announced in a statement.
The company’s product aims to assist children with autism and attention deficit hyperactivity disorder (ADHD) with maintaining focus, using an algorithm backed by artificial intelligence that sends vibration signals to a user wearing the device.
Revibe Technologies, Maker of a Wearable Device Being Developed for ADHD and Autism, Secures Over $3 Million in Funding, Appoints CEO as Company Enters New Growth Phase
New CEO brings significant experience in digital therapy, funding led by Carolina Angel Network
News provided by
Share this article
WAKE FOREST, N.C., April 15, 2021 /PRNewswire/
Revibe Technologies today announced they have raised over $3 million in new funding, led by Carolina Angel Network. The new capital will be invested in the clinical and regulatory development of Revibe s flagship digital therapeutic device, the AI-driven Revibe Connect smartwatch. The company also announced the hiring of Joseph Koziak as CEO, replacing founder Rich Brancaccio, who will transition to Chief Innovation Officer.